➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Colorcon
Johnson and Johnson
Merck
AstraZeneca

Last Updated: July 26, 2021

DrugPatentWatch Database Preview

Human c1-esterase inhibitor - Biologic Drug Details


Email this page to a colleague

« Back to Dashboard

Summary for human c1-esterase inhibitor
Tradenames:3
Patents:4
Applicants:2
BLAs:3
Suppliers: see list2
Recent Clinical Trials: See clinical trials for human c1-esterase inhibitor
Recent Clinical Trials for human c1-esterase inhibitor

Identify potential brand extensions & biosimilar entrants

SponsorPhase
AO GENERIUMPhase 2/Phase 3
IMMUNOe Research CentersPhase 4
Mansoura UniversityPhase 2

See all human c1-esterase inhibitor clinical trials

Patent Text Search: US Patents for human c1-esterase inhibitor

These patents were identified by searching patent claims

Supplementary Protection Certificates for human c1-esterase inhibitor

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/2001 Austria ⤷  Free Forever Trial PRODUCT NAME: RECOMBINANTES HUMANES OSTEOGENES PROTEIN-1 (OP 1); REGISTRATION NO/DATE: EU/1/01/179/001 20010517
C/GB01/022 United Kingdom ⤷  Free Forever Trial PRODUCT NAME: RECOMBINANT HUMAN LUTEINISING HORMONE; REGISTERED: UK EU/1/00/155/001-006 20001129
C0024 France ⤷  Free Forever Trial PRODUCT NAME: NATALIZUMAB,ANTICORPS MONOCLONAL HUMANISE ANTI-INTEGRINE ALPHA-4; REGISTRATION NO/DATE: EU/1/06/346/001 20060627
C/GB04/036 United Kingdom ⤷  Free Forever Trial PRODUCT NAME: INSULIN DETEMIR, NEB29- TETRADECANOYL- DES(B30) HUMAN INSULIN; NATL REGISTRATION NO/DATE: EU/1/04/278/001-009 20040601; FIRST REGISTRATION: CH 56370, 56311, 56372 20031110
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Medtronic
Express Scripts
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.